Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02085733 · ClinicalTrials.gov registry record

Pro-calcitonin for Early Detection of Septic Arthritis

A clinical trial of Arthritis, Infectious, sponsored by Children's Hospitals and Clinics of Minnesota.

Completed
Registry status
150
Enrollment target
1
Study location

NCT02085733: Completed study of Arthritis, Infectious, sponsored by Children's Hospitals and Clinics of Minnesota.

NCT02085733 is a study of Arthritis, Infectious that has completed, run by Children's Hospitals and Clinics of Minnesota. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02085733, a study of Arthritis, Infectious, has completed, sponsored by Children's Hospitals and Clinics of Minnesota.

COMPLETED
Registry status
150 participants
Enrollment target
1
Study location

Study Summary

Background: Children presenting with non-traumatic joint pain require different treatment depending on the cause of pain. Septic arthritis, which results from a bacterial infection in the joint, often requires a surgical procedure as well as a long course of antibiotics. In contrast, non-septic arthritis is typically treated by management of symptoms and observation. Current diagnostic standards involve microbiologic examination of fluid taken from the affected joint. This procedure can require the patient to be sedated, and the fluid culture analysis can take up to 72 hours. A single laboratory measure that could be easily obtained and quickly analyzed would aid in faster diagnosis, fewer diagnostic tests and lower cost of the diagnostic work-up for this condition. Recent research on septic arthritis has identified procalcitonin as a potential septic arthritis diagnostic indicator. Procalcitonin (PCT) is secreted by cells in the thyroid at higher levels when the body is facing infection. Procalcitonin levels rise slowly over the first two hours and peak at 24 hours. Levels rise 100-fold in the peripheral blood stream during this time frame. Several studies have indicated PCT is promising potential diagnostic indicator for septic arthritis. Unfortunately, many of these studies have relatively small sample sizes and very few involve pediatric populations. Additional study of PCT and septic arthritis in children will help evaluate the viability of PCT as a diagnostic indicator. Research Question: Can serum procalcitonin assist in clinical differentiation between bacterial (septic) and non-bacterial arthritis? Methods: Patients presenting with possible septic arthritis in the emergency department will be recruited for this study. Patients who consent to participate will receive the current standard for care, including IV placement, laboratory tests for Erythrocyte sedimentation rate (ESR),white blood cell count (WBC), and C-reactive protein (CRP), x-rays and cons

Primary Outcome

The primary outcome will be the presence or absence of septic joint. We will confirm the presence of a septic joint by the growth of bacteria in the synovial fluid or presumed septic arthritis if any of the following three criteria are present: a) \> 50,000 white cells in the synovial fluid, b) positive gram stain or c) positive blood culture in the setting of a swollen joint. For patients who do not undergo operative care, we will determine the presence or absence of septic joint by a templated

Conditions Studied

Study Locations (1)

Minnesota

  • Children's Hospitals and Clinics of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2014-02
Est. Completion 2016-12-31

What the finished NCT02085733 record still lists

NCT02085733 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.

The record links to 1 condition, with Arthritis, Infectious appearing as the primary indexed condition, and to 0 interventions.

NCT02085733 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT02085733 about?

NCT02085733 is a clinical study titled "Pro-calcitonin for Early Detection of Septic Arthritis". Background: Children presenting with non-traumatic joint pain require different treatment depending on the cause of pain. Septic arthritis, which results from a bacterial infection in the joint, often requires a surgical procedure as well as a long course of antibiotics. In contrast, non-septic art...

What is the current status of trial NCT02085733?

This trial is currently completed. The enrollment target is 150 participants. The study started on 2014-02. Estimated completion is 2016-12-31.

What conditions does trial NCT02085733 study?

This clinical trial studies the following conditions: Arthritis, Infectious.

Who is sponsoring clinical trial NCT02085733?

This trial is sponsored by Children's Hospitals and Clinics of Minnesota, which has 31 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02085733 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02085733, the US trial registry maintained by the National Library of Medicine. NCT02085733 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.